SEATTLE--(BUSINESS WIRE)--Presage Biosciences, an oncology company pioneering a radical new drug development approach that incorporates human efficacy data much earlier in development and clinical trials, announced today the formation of a Medical Advisory Panel to provide guidance on research and development strategies for Presage’s portfolio of novel oncology therapies.
